Literature DB >> 24323177

Pre-transplant left ventricular diastolic dysfunction is associated with post transplant acute graft rejection and graft failure.

Chetan Mittal1, Waqas Qureshi, Sumit Singla, Umair Ahmad, Mary Ann Huang.   

Abstract

INTRODUCTION: Acute cellular rejection (ACR) is a significant cause of morbidity and graft failure in liver transplant recipients (LTR). Diastolic dysfunction (DD) is frequently present in patients with cirrhosis undergoing liver transplantation. However, it is unclear if DD leads to ACR.
METHODS: Data was collected retrospectively for consecutive LTR between January 2000 and December 2010. Demographic data and mortality related data was obtained from social security index. Primary outcome was biopsy proven ACR. Graft failure and all-cause mortality were also evaluated. DD was evaluated as a predictor of these outcomes. Other echocardiographic indices were also assessed as predictors of ACR by using Cox proportional hazard modeling adjusted for covariates.
RESULTS: A total of 970 LTR (mean age 53.2 ± 10 years, women 34.6 % and white 64.5 %) were followed for 5.3 ± 3.4 years. Patients with DD (n = 145, 14.9 %) were significantly more likely to develop ACRs (HR 10.56; 95 % CI 6.78-16.45, p value = 0.0001) as well as graft failure (HR 2.09; 95 % CI 1.22-3.59, p value = 0.007) and all-cause mortality (HR 1.52; 95 % CI 1.08-2.13, p = 0.01). There was an increase in the risk of these outcomes with worsening of DD, when adjusted for various risk factors such as donor and recipient age, gender, race, Framingham risk score, pre-transplant MELD, transplant etiology and cold ischemia time.
CONCLUSION: Pre-transplant DD is significantly associated with increased risk of allograft rejection, graft failure and mortality. This signifies the importance of cardiac evaluation during the pre-transplant period.

Entities:  

Mesh:

Year:  2013        PMID: 24323177     DOI: 10.1007/s10620-013-2955-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Liver transplantation in high-risk patients: hepatopulmonary syndrome and portopulmonary hypertension.

Authors:  G Martínez-Palli; P Taurà; J Balust; J Beltrán; E Zavala; J C Garcia-Valdecasas
Journal:  Transplant Proc       Date:  2005-11       Impact factor: 1.066

Review 2.  What is the long-term outcome of the liver allograft?

Authors:  Stefan G Hübscher
Journal:  J Hepatol       Date:  2011-03-21       Impact factor: 25.083

Review 3.  Banff schema for grading liver allograft rejection: an international consensus document.

Authors: 
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

4.  Association of TNF-α with left ventricular diastolic dysfunction in patients with hepatitis C virus infection.

Authors:  Wenliang Che; Ban Liu; Fei Nie; Yidong Wei; Weiming Li; Wei Chen; Yawei Xu
Journal:  Int J Cardiol       Date:  2013-05-04       Impact factor: 4.164

5.  Increased serum N-terminal pro-B-type natriuretic peptide and left ventricle diastolic dysfunction in patients with hepatitis C virus infection.

Authors:  W Che; W Liu; Y Wei; Y Xu; L Hou; A Matsumori; D Hu
Journal:  J Viral Hepat       Date:  2011-11-17       Impact factor: 3.728

6.  Doppler-echocardiographic indices of diastolic function in heart failure admissions with preserved left ventricular systolic function.

Authors:  John M Cahill; Mairead Horan; Peter Quigley; Brian Maurer; Ken McDonald
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

7.  Nuclear factor-kappaB inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy.

Authors:  Hongqun Liu; Samuel S Lee
Journal:  Liver Int       Date:  2008-03-11       Impact factor: 5.828

8.  Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.

Authors:  Ryan A McTaggart; Norah A Terrault; Andrew J Vardanian; Alan Bostrom; Sandy Feng
Journal:  Liver Transpl       Date:  2004-08       Impact factor: 5.799

9.  Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation.

Authors:  Taylor F Dowsley; David B Bayne; Alan N Langnas; Ioana Dumitru; John R Windle; Thomas R Porter; Eugenia Raichlin
Journal:  Transplantation       Date:  2012-09-27       Impact factor: 4.939

10.  Late acute rejection after liver transplantation: the Western Canada experience.

Authors:  Alnoor Ramji; Eric M Yoshida; Vincent G Bain; Norman M Kneteman; Charles H Scudamore; Mang M Ma; Urs P Steinbrecher; Klaus S Gutfreund; Siegfried R Erb; Nilufar Partovi; Stephen W Chung; James Shapiro; Winnie W S Wong
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

View more
  20 in total

Review 1.  Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients.

Authors:  Suehana Rahman; Susan V Mallett
Journal:  World J Hepatol       Date:  2015-03-27

2.  Assessment of diastolic function in the management of patients with cirrhosis.

Authors:  Søren Møller
Journal:  Hepatol Int       Date:  2014-07-27       Impact factor: 6.047

Review 3.  Echocardiography in the Liver Transplant Patient.

Authors:  Parul Kakar; James Gubitosa; Christine Gerula
Journal:  Curr Cardiol Rep       Date:  2021-07-03       Impact factor: 2.931

4.  Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.

Authors:  Achintya D Singh; Andrew Ford; Ruishen Lyu; Habib Layoun; Serge C Harb; Maan Fares; William D Carey
Journal:  Dig Dis Sci       Date:  2022-02-12       Impact factor: 3.487

Review 5.  Diastolic dysfunction in cirrhosis.

Authors:  Søren Møller; Signe Wiese; Hanne Halgreen; Jens D Hove
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 6.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 7.  Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.

Authors:  Csaba Matyas; György Haskó; Lucas Liaudet; Eszter Trojnar; Pal Pacher
Journal:  Nat Rev Cardiol       Date:  2020-09-30       Impact factor: 32.419

8.  Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.

Authors:  Madhumita Premkumar; Devaraja Devurgowda; Tanmay Vyas; Saggere M Shasthry; Jelen S Khumuckham; Ritu Goyal; Sherin S Thomas; Guresh Kumar
Journal:  J Clin Exp Hepatol       Date:  2018-08-30

Review 9.  Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation.

Authors:  Blessing Aghaulor; Lisa B VanWagner
Journal:  Clin Liver Dis       Date:  2020-10-26       Impact factor: 6.126

10.  Cirrhotic cardiomyopathy: Appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes.

Authors:  Ashley Spann; Christopher Coe; Teminioluwa Ajayi; Garren Montgomery; Mohammed Shwetar; Adesola Oje; Jeffrey Annis; James C Slaughter; Sophoclis Alexopoulos; Evan Brittain; Manhal Izzy
Journal:  Liver Transpl       Date:  2022-06-16       Impact factor: 6.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.